Main description:

Emerging Nanomedicines for Diabetes Mellitus Theranostics provides readers with information on the development of efficacious nanomedicines as potential theranostic agents for diabetes. The book discusses the application of various novel nanomaterials and nanocomposites for targeted delivery of insulin, glucose sensing, including nano-tattoos as glucose monitors, biosynthesized nanoparticles for diabetes treatment, and pre-clinical and clinical assays to evaluate the efficacy of nanomedicines for diabetes treatment. This is an important references source for materials scientists, pharmaceutical scientists and biomedical engineers who want to increase their understanding of how nanotechnology is being used to improve diabetes treatment.

Diabetes has emerged as one of the most common diseases associated with lifestyle choices in the modern world, with significant mortality rates. Conventional treatment methods mainly involve insulin-based therapies. However, insulin therapy possesses several limitations such as weight gain and hypoglycemia. Thus, advanced research in nanomedicine is targeting the development of new and improved diagnostics and treatment methods for diabetes.

Contents:

1. The current state of diabetes treatment 2. Nanoparticles and nanocomposites for controlled delivery of insulin 3. Nanomaterials as glucose sensors for diabetes monitoring 4. Nano-tattoos-a novel approach for glucose monitoring and diabetes management 5. Metal and metal oxide nanoparticles: synthesis, properties, and applications as nanomedicines for diabetes treatment 6. Biosynthesized nanoparticles for diabetes treatment 7. Cytotoxicity of nanoparticles toward diabetic cell models 8. In vivo studies of nanoparticles in diabetic models 9. Preclinical and clinical evaluation of nanodrugs for diabetes treatment 10. Future of nanoparticles, nanomaterials, and nanomedicines in diabetes treatment